BioNTech SE BNTX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/12/21 EDT
183.50quote price arrow down-2.63 (-1.41%)
Volume
24,868
Close
186.13UNCH (UNCH)
Volume
3,135,742
52 week range
45.08 - 213.15

...

Loading . . .
  • Open196.65
  • Day High198.19
  • Day Low185.66
  • Prev Close198.02
  • 52 Week High213.15
  • 52 Week High Date05/04/21
  • 52 Week Low45.08
  • 52 Week Low Date05/14/20

Key Stats

  • Market Cap44.954B
  • Shares Out241.52M
  • 10 Day Average Volume6.04M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change128.32

KEY STATS

  • Open196.65
  • Day High198.19
  • Day Low185.66
  • Prev Close198.02
  • 52 Week High213.15
  • 52 Week High Date05/04/21
  • 52 Week Low45.08
  • 52 Week Low Date05/14/20
  • Market Cap44.954B
  • Shares Out241.52M
  • 10 Day Average Volume6.04M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change128.32

RATIOS/PROFITABILITY

  • EPS (TTM)5.04
  • P/E (TTM)36.93
  • Fwd P/E (NTM)7.19
  • EBITDA (MRQ)2.043B
  • ROE (MRQ)80.65%
  • Revenue (MRQ)3.04B
  • Gross Margin (MRQ)88.55%
  • Net Margin (MRQ)47.81%
  • Debt To Equity (MRQ)26.07%

EVENTS

  • Earnings Date08/12/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
372.84UNCHUNCH
SGEN
Seagen Inc
144.77UNCHUNCH
MRNA
Moderna Inc
152.68UNCHUNCH
GMAB
Genmab A/S
36.33UNCHUNCH
INCY
Incyte Corp
82.37UNCHUNCH